Due to the COVID-19 pandemic, the ACP office is now closed as our staff work remotely. Click here to see how this impacts our programs and operations.

News

Know an outstanding UAlberta Pharmacy Alumnus?

June 29, 2016

If you know of someone who is making significant contributions to the profession, their community, to society at large, or to the Faculty of Pharmacy and Pharmaceutical Sciences, nominate them today for an Outstanding Pharmacy Alumnus Award! The awards will be presented in the fall. Deadline for...

Pharmacy technicians: Have you reviewed the CCP tutorial yet?

June 29, 2016

One of the first steps you should take in your Continuing Competence Program (CCP) journey is to complete the CCP tutorial. This will help you gain a better understanding of the program and its requirements. The tutorial is available in the Self-Assessment/...

Administration of methotrexate injections

June 15, 2016

We have received several questions about administering methotrexate injections in pharmacies. Although we do not have a specific policy about methotrexate, we have been working with the College of Physicians and Surgeons of Alberta and the College and Association of Registered Nurses of Alberta to develop...

Green and Gold Pub Night - June 24, 2016, Calgary

June 1, 2016

Calling all U of A Pharmacy alumni! The Faculty of Pharmacy and Pharmaceutical Sciences is kicking off this year’s Canadian Pharmacists Conference with a bang and you’re invited! The University of Alberta Calgary Centre, located just minutes from the conference hotel, will be converted...

Input needed for future kidney health education event

June 1, 2016

In partnership with the Alberta Renal Programs and Divisions of Nephrology, the Kidney Health Strategic Clinical Network is planning on hosting Alberta Kidney Days, an educational event targeted at providers with an interest in kidney health. 

Reminder about requirements for clozapine therapy

June 1, 2016

ACP recently received a report about a community pharmacy dispensing clozapine to a patient without contacting a clozapine registry, or ensuring it was appropriate for the patient to be dispensed this medication. The patient previously experienced a significant adverse reaction to...